JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2017, Vol. 31 ›› Issue (4): 98-102.doi: 10.6040/j.issn.1673-3770.0.2016.228
Previous Articles Next Articles
YAN Xin, WANG Cui, ZHAO Bojun
CLC Number:
[1] Imamura Y, Engelbert M, Iida T, et al. Polypoidal choroidal vasculopathy: a review[J]. Surv Ophthalmol, 2010, 55(6):501-515. [2] Laude A, Cackett PD, Vithana EN, et al. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease?[J]. Prog Retin Eye Res, 2010, 29(1):19-29. [3] Byeon SH, Lee SC, Oh HS, et al. Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients[J]. Jpn J Ophthalmol, 2008, 52(1):57-62. [4] Honda S, Matsumiya W, Negi A. Polypoidal choroidal vasculopathy: clinical features and genetic predisposition[J]. Ophthalmologica, 2014, 231(2):59-74. [5] Wong RL, Lai TY. Polypoidal choroidal vasculopathy: an update on therapeutic approaches[J]. J Ophthalmic Vis Res, 2013, 8(4):359-371. [6] Maruko I, Iida T, Saito M, et al. Clinical characteristics of exudative age-related macular degeneration in Japanese patients[J]. Am J Ophthalmol, 2007, 144(1):15-22. [7] Liu Y, Wen F, Huang S, et al. Subtype lesions of neovascular age-related macular degeneration in Chinese patients[J]. Graefes Arch Clin Exp Ophthalmol, 2007, 245(10):1441-1445. [8] Cackett P, Wong D, Yeo I. A classification system for polypoidal choroidal vasculopathy[J]. Retina, 2009, 29(2):187-191. [9] Tsujikawa A, Nakanishi H, Ojima Y, et al. Macular polypoidal choroidal vasculopathy with a remote lesion[J]. Clin Exp Ophthalmol, 2008, 36(9):817-823. [10] Kwok AK, Lai TY, Chan CW, et al. Polypoidal choroidal vasculopathy in Chinese patients[J]. Br J Ophthalmol, 2002, 86(8):892-897. [11] Yamaoka S, Okada AA, Sugahara M, et al. Clinical features of polypoidal choroidal vasculopathy and visual outcomes in the absence of classic choroidal neovascularization[J]. Ophthalmologica, 2010, 224(3):147-152. [12] Japanese Study Group of Polypoidal Choroidal Vasculopathy. Criteria for diagnosis of polypoidal choroidal vasculopathy[M]. Japanese: Nippon Ganka Gakkai Zasshi, 2005:417-427. [13] Tan CS, Ngo WK, Chen JP, et al. EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy[J]. Br J Ophthalmol, 2015, 99(5):624-628. [14] Hou J, Tao Y, Li XX, et al. Clinical characteristics of polypoidal choroidal vasculopathy in Chinese patients[J]. Graefes Arch Clin Exp Ophthalmol, 2011, 249(7):975-979. [15] Wen F, Chen C, Wu D, et al. Polypoidal choroidal vasculopathy in elderly Chinese patients[J]. Graefes Arch Clin Exp Ophthalmol, 2004, 242(8):625-629. [16] Lafaut BA, Leys AM, Snyers B, et al. Polypoidal choroidal vasculopathy in Caucasians[J]. Graefes Arch Clin Exp Ophthalmol, 2000, 238(9):752-759. [17] Yannuzzi LA, Wong DW, Sforzolini BS, et al. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration[J]. Arch Ophthalmol, 1999, 117(11):1503-1510. [18] Ciardella AP, Donsoff IM, Huang SJ, et al. Polypoidal choroidal vasculopathy[J]. Surv Ophthalmol, 2004, 49(1):25-37. [19] Sho K, Takahashi K, Yamada H, et al. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics[J]. Arch Ophthalmol, 2003, 121(10):1392-1396. [20] Hayashi H, Yamashiro K, Gotoh N, et al. CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation[J]. Invest Ophthalmol Vis Sci, 2010, 51(11):5914-5919. [21] 刘会娟, 陈中山, 丁琴, 等. 362例息肉样脉络膜血管病变患者的临床特征分析[J]. 中华眼底病杂志, 2013, 29(4):376-379. LIU Huijuan, CHEN Zhongshan, DING Qin, et al. Clinical characteristics of 362 cases of polypoidal choroidal vasculopathy[J]. Chin J Ocul Fund Dis, 2013, 29(4):376-379. [22] 刘冉, 李加青, 曾婧, 等. 渗出型老年性黄斑变性与息肉样脉络膜血管病变患者年龄、性别及发病眼别的比较[J]. 中华眼底病杂志, 2012, 28(5):445-448. LIU Ran, LI Jiaqing, ZENG Jing, et al. Compare neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in age at diagnosis, gender and disease laterality[J]. Chin J Ocul Fund Dis, 2012, 28(5):445-448. [23] Scassellati-Sforzolini B, Mariotti C, Bryan R, et al. Polypoidal choroidal vasculopathy in Italy[J]. Retina, 2001, 21(2):121-125. [24] Mori K, Horie-Inoue K, Gehlbach PL, et al. Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population[J]. Ophthalmology, 2010, 117(5):928-938. [25] Cackett P, Htoon H, Wong D, et al. Haemorrhagic pigment epithelial detachment as a predictive feature of polypoidal choroidal vasculopathy in a Chinese population[J]. Eye(Lond), 2010, 24(5):789-792. [26] 史雪辉, 魏文斌, 田蓓, 等. 脉络膜新生血管的病变特征分析[J]. 中华眼科杂志, 2008, 44(9):780-785. SHI Xuehui, WEI Wenbin, TIAN Bei, et al. Analysis of clinical features of choroidal neovascularization[J]. Chin J Ophthalmol, 2008, 44(9):780-785. [27] Yeung L, Chen SN. Polypoidal choroidal vasculopathy in Taiwan[J]. Chang Gung Med J, 2004, 27(5):366-372. [28] Cheung CM, Laude A, Wong W, et al. Improved specificity of polypoidal choroidal vasculopathy diagnosis using a modified everest criteria[J]. Retina, 2015, 35(7):1375-1380. [29] Suzuki M, Nagai N, Shinoda H, et al. Distinct responsiveness to intravitreal ranibizumab therapy in polypoidal choroidal vasculopathy with single or multiple polyps[J]. Am J Ophthalmol, 2016, 166:52-59. |
[1] | WANG Xian, LI Ying, ZHAO Bojun. Advances in diagnosis and treatment of polypoid choroidal vasculopathy [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 103-106. |
[2] | LÜ Dan, LI Mingxia, MA Lanzhi, ZHANG Xinyuan, XIAO Hao, CHEN Fei, LIU Jun, LI Zhen. Neurofibromatosis of the head and neck involving the mediastinum: two cases report [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(1): 82-86. |
[3] | DU Ran, WANG Jialin, WANG Yanling. Different clinical manifestations of retinitis pigmentosa and related imaging features [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(5): 87-90. |
|